title: [Structural abnormalities and inflammation in COPD: a focus on small airways].
abstract: Chronic obstructive pulmonary disease (COPD) is characterized by poorly reversible airflow limitation associated with airway remodelling and inflammation of both large and small airways. The site of airflow obstruction in COPD is located in the small airways, justifying a focus on this compartment. The structural abnormalities that are found in bronchioles with a diameter less than 2mm are characterized by increased airway wall thickness with peribronchial fibrosis, and by luminal obstruction by mucous exudates. Destruction of alveolar walls, the hallmark of emphysema, may be related to protease-antiprotease imbalance, and to mechanisms involving apoptosis, senescence, and autoimmunity. Cigarette smoke inhalation triggers the recruitment of innate immune cells (neutrophils and macrophages) and putatively adaptive immunity mediated via T and B lymphocytes and lymphoid follicles in the small airways. These data suggest a potential role for therapies that can target remodelling and inflammation in the small airways of patients with COPD.
authors: Service de pneumologie, hôpital Cochin, AP-HP, université Paris Descartes, Paris, France. pierre-regis.burgel@cch.aphp.fr
authors: P-R
authors: PR
authors: Burgel
authors: A
authors: A
authors: Bourdin
authors: C
authors: C
authors: Pilette
authors: G
authors: G
authors: Garcia
authors: P
authors: P
authors: Chanez
authors: I
authors: I
authors: Tillie-Leblond
mesh_terms: D056704:Adaptive Immunity; D056151:Airway Remodeling / Q000276:immunology / Q000502:physiology; D017209:Apoptosis; D015551:Autoimmunity; D055745:Bronchioles / Q000473:pathology*; D002634:Chemotaxis, Leukocyte; D016207:Cytokines / Q000378:metabolism; D004848:Epithelium / Q000473:pathology; D005355:Fibrosis; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology; D007249:Inflammation; D016131:Lymphocyte Subsets / Q000276:immunology; D009093:Mucus / Q000378:metabolism; D009504:Neutrophils / Q000276:immunology; D010447:Peptide Hydrolases / Q000502:physiology; D011650:Pulmonary Alveoli / Q000098:blood supply / Q000473:pathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000276:immunology / Q000473:pathology*; D011656:Pulmonary Emphysema / Q000209:etiology / Q000276:immunology / Q000473:pathology; D012907:Smoking / Q000009:adverse effects / Q000276:immunology
chemical_list: D016207:Cytokines; D010447:Peptide Hydrolases